Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Biology & Therapy|August 14, 2008
IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activityStephen G Maher, Faruk Sheikh, Anthony J Scarzello, et al.
Frontiers in Immunology|August 29, 2018
Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8+ T Cell Accumulation in the Omentum of Obesity-Associated Cancer PatientsMelissa J Conroy, Stephen G Maher, Ashanty M Melo, et al.
Pharmaceuticals (Basel, Switzerland)|February 23, 2019
Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma CellsAmy M Buckley, Becky As Bibby, Margaret R Dunne, et al.
Scientific Reports|January 28, 2018
Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell linesSusan Heavey, Paul Dowling, Gillian Moore, et al.
Molecular Biology of the Cell|April 20, 2007
A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosisAnthony J Scarzello, Ana L Romero-Weaver, Stephen G Maher, et al.
Molecular Medicine (Cambridge, Mass.)|June 3, 2016
Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinomaNiamh Lynam-Lennon, Becky A Bibby, Ann Marie Mongan, et al.
Cancer Letters|December 24, 2024
Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxiaMaitiú Ó Murchú, Xuehua Lin, Melissa Anne Tutty, et al.
Annals of Surgery|October 6, 2009
Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancerStephen G Maher, Charles M Gillham, Shane P Duggan, et al.
Cancer Letters|January 22, 2019
Pyrazinib (P3), [(E)-2-(2-Pyrazin-2-yl-vinyl)-phenol], a small molecule pyrazine compound enhances radiosensitivity in oesophageal adenocarcinomaAmy M Buckley, Margaret R Dunne, Niamh Lynam-Lennon, et al.
The British Journal of Radiology|January 12, 2021
PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinomaSarah D Edge, Isaline Renard, Emily Pyne, et al.
Pageof 5